Fundraising Fox
🦊/People
Sign in

Stella Xu

Investor

Managing Director at Quan Capital · Board director at Tempest Therapeutics

Zwolle, Overijssel, Netherlands

Find your path to Stella

412 people in our graph share verified history with Stella — schools, employers, funds. One of them is your warm intro.

Stephane KurganunlockedStella: together at McKinsey & Company (1998–1999)
×11Stella: together at McKinsey & Company

About

Stella Xu is Managing Director of Quan Capital, a life sciences venture fund with offices in China and the US, focusing on cross-border value creation and global investments. Before joining Quan, she held R&D leadership roles at Roche, including VP/Site Head of Roche Innovation Center Shanghai, and earlier led healthcare management consulting engagements at McKinsey in the US. She holds a Ph.D. in Immunology from Northwestern University and a B.S. in Biophysics from Peking University.

Contact· self-published, not guessed

Invests in

BiotechHealthtech

Board director at Tempest Therapeutics

Intro paths

→

In turn, Stella can intro founders to Tempest Therapeutics's investors below.

Tempest Therapeutics's investors · 6

F-Prime CapitalCambridge · $3M – $10M checks · since 2020LAVHong Kong · $5M – $15M checksLilly Asia VenturesHong KongNew Enterprise Associates (NEA)Menlo Park · $200K – $40M checksQuan CapitalShanghaiRoche Venture FundBasel · $648K – $3.2M checks

Experience

  1. Quan Capital 泉创资本Managing Directorcurrent2017 — presentSan Francisco Bay Area
  2. RocheVice President & Site Head, Pharma Research & Early Development (pRED) China2012 — 2017Shanghai, China
  3. RocheExecutive Director2002 — 2012New Jersey, US; Shanghai, China
  4. McKinsey & CompanyEngagement Manager1998 — 2002New Jersey; California
  5. Ionis Pharmaceuticals, Inc.Scientist1996 — 1998

Skills & more

Strategic Planning20Global Business Development20China Business Development6Licensing33Global Alliance Management9Management Consulting13Strategic marketing1Pharmaceutical/biotech R&D1R&D general management1Healthcare M&A1

From Stella's professional profile.

Investments

Board seats

Armo BioSciencesCentrexion TherapeuticsDesign TherapeuticsHBM Healthcare InvestmentNextCureTempest TherapeuticsTherorna Inc.Zidan Medical

Per the firm's website.

Colleagues at Quan Capital

Angela Shen
Senior Advisor at Quan Capital
Cherry Jin
Executive Assistant at Quan Capital
Crystal Yin
Director, Finance at Quan Capital
Harald Reinhart
Venture Partner at Quan Capital
John Wong
Venture Partner at Quan Capital
Kui Wang
Senior Associate at Quan Capital
Lena Guo
Operation Manager at Quan Capital
Marietta Wu
Managing Director at Quan Capital

Frequently asked questions

Who is Stella Xu?
Stella Xu is Managing Director of Quan Capital, a life sciences venture fund with offices in China and the US, focusing on cross-border value creation and global investments. Before joining Quan, she held R&D leadership roles at Roche, including VP/Site Head of Roche Innovation Center Shanghai, and earlier led healthcare management consulting engagements at McKinsey in the US. She holds a Ph.D. in Immunology from Northwestern University and a B.S. in Biophysics from Peking University.
Where does Stella Xu work?
Stella Xu is Managing Director at Quan Capital and Board director at Tempest Therapeutics.
What does Stella Xu invest in?
Stella Xu invests in Biotech, Healthtech.
What boards does Stella Xu sit on?
Stella Xu holds tracked board seats at Armo BioSciences, Centrexion Therapeutics, Design Therapeutics, HBM Healthcare Investment, NextCure, Tempest Therapeutics, Therorna Inc., Zidan Medical.
Where did Stella Xu go to school?
Stella Xu studied at Northwestern University (Ph.D., Molecular Immunology); Peking University (B.S., Biophysics).

Same school

Shared employers